Immuneering Corp
IMRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001790340
No open-market purchases or sales by Immuneering Corp insiders were filed in the last 90 days; 111 institutions reported holding it in 13F filings for Q2 2026, worth $171.6M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Immuneering Corp as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +1 vs. Q4 2022
- Shares held
- 11.8M
- +88.4K (+0.8%) vs. Q4 2022
- Total value
- $114.9M
- +$58.0M (+102.0%) vs. Q4 2022
- New holders
- 6
- 13 more added
- Sold out
- 5
- 12 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $171.6M |
| Q1 2026 | 96 | $154.3M |
| Q4 2025 | 85 | $208.6M |
| Q3 2025 | 69 | $183.3M |
| Q2 2025 | 39 | $12.9M |
| Q1 2025 | 35 | $6.84M |
| Q4 2024 | 42 | $9.32M |
| Q3 2024 | 38 | $10.9M |
| Q2 2024 | 59 | $12.3M |
| Q1 2024 | 51 | $34.3M |
| Q4 2023 | 52 | $118.6M |
| Q3 2023 | 52 | $130.1M |
| Q2 2023 | 49 | $175.9M |
| Q1 2023 | 35 | $114.9M |
| Q4 2022 | 34 | $56.9M |
| Q3 2022 | 32 | $172.5M |
| Q2 2022 | 37 | $65.7M |
| Q1 2022 | 50 | $88.1M |
| Q4 2021 | 37 | $200.1M |
| Q3 2021 | 38 | $316.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Immuneering Corp; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Price T Rowe Associates Inc | 3,458,368 | $33.6M | 0.01% | −161,192−4.5% | Reduced |
| Cormorant Asset Management, LP | 2,386,181 | $23.2M | 1.53% | +100,000+4.4% | Added |
| Citadel Advisors LLC | 2,104,653 | $20.4M | 0.02% | −36,844−1.7% | Reduced |
| BlackRock Inc. | 1,340,193 | $13.0M | 0.00% | −8,191−0.6% | Reduced |
| Vanguard Group Inc | 875,968 | $8.51M | 0.00% | +38,289+4.6% | Added |
| FMR LLC | 402,521 | $3.91M | 0.00% | +249,458+163.0% | Added |
| Adage Capital Partners GP, L.L.C. | 205,000 | $1.99M | 0.00% | +130,000+173.3% | Added |
| Geode Capital Management, LLC | 169,219 | $1.64M | 0.00% | 00.0% | Unchanged |
| TD Asset Management Inc | 144,103 | $1.40M | 0.00% | −2,611−1.8% | Reduced |
| Bank of Montreal | 96,028 | $1.01M | 0.00% | +96,028 | New |
| Millennium Management LLC | 98,786 | $959.0K | 0.00% | +79,116+402.2% | Added |
| ExodusPoint Capital Management, LP | 86,297 | $838.0K | 0.01% | +86,297 | New |
| Manufacturers Life Insurance Company, The | 82,547 | $801.5K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 57,949 | $562.7K | 0.00% | +12,949+28.8% | Added |
| State Street Corp | 53,735 | $521.8K | 0.00% | −300−0.6% | Reduced |
| CI Private Wealth, LLC | 46,654 | $453.0K | 0.00% | −765−1.6% | Reduced |
| Jane Street Group, LLC | 46,571 | $452.2K | 0.00% | +46,571 | New |
| Bridgeway Capital Management, LLC | 39,049 | $379.2K | 0.01% | +4,100+11.7% | Added |
| Northern Trust Corp | 37,300 | $362.2K | 0.00% | +2,640+7.6% | Added |
| Morgan Stanley | 27,651 | $268.5K | 0.00% | −17,765−39.1% | Reduced |
| Goldman Sachs Group Inc | 26,211 | $254.5K | 0.00% | +15,934+155.0% | Added |
| Man Group plc | – | $118.2K | 0.00% | – | – |
| Y-Intercept (Hong Kong) Ltd | 11,114 | $107.9K | 0.01% | +11,114 | New |
| Barclays PLC | 5,217 | $50.7K | 0.00% | −1,541−22.8% | Reduced |
| Tower Research Capital LLC (TRC) | 2,768 | $27.0K | 0.00% | −3,608−56.6% | Reduced |
| UBS Group AG | 2,713 | $26.3K | 0.00% | +2,713 | New |
| Bank of America Corp | 2,392 | $23.2K | 0.00% | +1,861+350.5% | Added |
| JPMorgan Chase & Co | 1,030 | $10.0K | 0.00% | +70+7.3% | Added |
| China Universal Asset Management Co., Ltd. | 358 | $3.48K | 0.00% | +90+33.6% | Added |
| Cary Street Partner Investment Advisory LLC | 301 | $2.92K | 0.00% | +301 | New |
| Citigroup Inc | 300 | $2.91K | 0.00% | −103−25.6% | Reduced |
| Wells Fargo & Company | 126 | $1.22K | 0.00% | +2+1.6% | Added |
| Daiwa Securities Group Inc. | 76 | $1.00K | 0.00% | 00.0% | Unchanged |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 5 | $49 | 0.00% | −4,143−99.9% | Reduced |
| Royal Bank of Canada | 5 | $0 | 0.00% | −76−93.8% | Reduced |
| T. Rowe Price Investment Management, Inc. | 0 | $0 | 0.00% | −458,233−100.0% | Sold out |
| Anson Funds Management LP | 0 | $0 | 0.00% | −32,603−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −23,371−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −19,394−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −58−100.0% | Sold out |